Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Data Verification
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > COVID-19

COVID-19

Advisory to Protect/ Support Pharmacists on the Coronavirus (COVID-19) Frontline

Ijaz Mustafa COVID-19 April 16, 2020January 18, 2022
Advisory-to-Protect-Support-Pharmacists-on-the-Coronavirus-FrontlineDownload

Safety Alert of Falsified Chloroquine Products Circulating in the WHO Region of Africa

Ijaz Mustafa COVID-19 April 15, 2020January 18, 2022
Safety-Alert-of-Falsified-Chloroquine-Products-Circulating-in-the-WHO-Region-of-AfricaDownload

Safety Alert of Falsified Medical Products, including In Vitro Diagnostics, that claim to Prevent, Detect, Treat or Cure COVID-19

Ijaz Mustafa COVID-19 April 14, 2020January 18, 2022
Safety-Alert-of-Falsified-Medical-Products-including-in-Vitro-Diagnostics-that-claim-to-Prevent-Detect-Treat-or-Cure-COVID-19Download

Letter of cases of sanitizers permitted in 76th meeting of EEC held on 10th April, 2020

Ijaz Mustafa COVID-19 April 14, 2020January 18, 2022
Letter-of-cases-of-sanitizers-permitted-in-76th-meeting-of-EEC-held-on-10th-April-2020Download

[Revised Version] Guidance Document of Technical committee constituted by PEC to prepare Fast Track Acceptance Test Procedure for Locally Developed Mechanical Ventilators

Ijaz Mustafa COVID-19 April 13, 2020January 18, 2022
Guidance-Document-of-Technical-committee-constituted-by-PEC-to-prepare-Fast-Track-Acceptance-Test-Procedure-for-Locally-Developed-MechanicalVentilators-for-COVID-19-PandemicDownload

Letter of Permission to Prepare Hand Sanitizers

Ijaz Mustafa COVID-19 April 10, 2020January 18, 2022
Letter-of-Permission-to-Prepare-Hand-SanitizersDownload

Notification regarding Hand Sanitizer

Ijaz Mustafa COVID-19 April 6, 2020January 18, 2022
Notification-SanitizerDownload

Ensuring prescription-based sale of Hydroxychloroquine and Azithromycin containing dosage forms

Ijaz Mustafa COVID-19 March 27, 2020January 18, 2022
Ensuring-prescription-based-sale-of-hydroxychloroquine-and-azithromycin-containing-dosage-formsDownload

Emergency supplies of medical devices in corona virus (covid-19) pandemic

Ijaz Mustafa COVID-19 March 23, 2020January 18, 2022
Emergency-supplies-of-medical-devices-in-corona-virus-covid-19-pandemicDownload

Ensuring prescription-based sale of Chloroquine Phosphate containing dosage forms

Ijaz Mustafa COVID-19 March 2, 2020January 18, 2022
Ensuring-prescription-based-sale-of-chloroquine-phosphate-containing-dosage-formsDownload
  • ← Previous
  • Next →
  • New & Updates
  • COVID-19 Drugs Availability
  • Government of Pakistan COVID-19 Portal
  • National Command Operation Center (NCOC)
  • Ministry of NHSR&C
  • WHO – Coronavirus disease

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem